Discover 1,567 paid clinical trials in Paterson, New Jersey. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,567
Study Evaluating UCART20x22 in B-Cell Non-Hodgkin Lymphoma
for
B-cell Non-Hodgkin Lymphoma (B-NHL)
Location: New Brunswick NJ, Boston MA, Chicago IL, Austin TX
Sponsor: Cellectis S.A.
Sex: All
Age: 18 - 70+
Code: NCT05607420
Phase1, Phase2, Recruiting
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
for
Attention-Deficit/Hyperactivity Disorder
Location: Irvington NJ, New York NY, Neptune City NJ, Hershey PA,
Sponsor: Supernus Pharmaceuticals, Inc.
Sex: All
Age: 4 - 5
Code: NCT04781140
Recruiting
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
for
COPD (Chronic Obstructive Pulmonary Disease)
Location: New York NY, The Bronx NY, New Windsor NY,
Sponsor: AstraZeneca
Sex: All
Age: 40 - 70+
Code: NCT06283966
Phase3, Recruiting
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
Location: New York NY, Manhasset NY, New Brunswick NJ,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06465810
Recruiting
Safety and Efficacy of APC-0101 in Preterm Infants With Respiratory Distress Syndrome
for
Respiratory Distress Syndrome, Pre-term Infants
Location: New York NY, The Bronx NY, Morristown NJ, Valhalla NY,
Sponsor: Aerogen Pharma Limited
Sex: All
Age: 0
Code: NCT06776783
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia
for
Barretts Esophagus With Dysplasia, Barrett Esophagus,
Location: New York NY, Manhasset NY, Camden NJ, Philadelphia PA,
Sponsor: University of Colorado, Denver
Sex: All
Age: 18 - 70+
Code: NCT05753748
Recruiting
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
for
Metastatic Castration-resistant Prostate Cancer (mCRPC),
Location: New Brunswick NJ, New Haven CT, Philadelphia PA,